JOURNAL OF PSYCHOACTIVE DRUGS

Scope & Guideline

Unraveling the Science Behind Psychoactive Experiences

Introduction

Welcome to the JOURNAL OF PSYCHOACTIVE DRUGS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF PSYCHOACTIVE DRUGS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0279-1072
PublisherROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1967 to 1972, from 1974 to 2024
AbbreviationJ PSYCHOACTIVE DRUGS / J. Psychoact. Drugs
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND

Aims and Scopes

The 'Journal of Psychoactive Drugs' focuses on a multidisciplinary approach to the study of psychoactive substances and their effects, encompassing various aspects of drug use, including health, psychology, sociology, and policy. The journal aims to advance the understanding of psychoactive drugs through empirical research, theoretical frameworks, and reviews that highlight the complexities surrounding substance use and its societal implications.
  1. Psychedelic Research and Therapeutics:
    The journal emphasizes the therapeutic potential of psychedelics, exploring their use in treating mental health disorders, substance use disorders, and other psychological conditions.
  2. Substance Use Epidemiology:
    Research focusing on the prevalence, patterns, and correlates of psychoactive substance use across different populations, including marginalized and vulnerable groups.
  3. Cultural and Social Contexts of Drug Use:
    Investigates the cultural, social, and community aspects of drug use, including stigma, identity, and the impact of drug policies on different populations.
  4. Harm Reduction Strategies:
    Promotes research on harm reduction approaches, assessing their effectiveness and implementation in various settings, particularly for high-risk substance users.
  5. Psychosocial Factors and Substance Use:
    Examines the psychological, social, and behavioral factors that influence substance use, including coping strategies, mental health comorbidities, and recovery processes.
The 'Journal of Psychoactive Drugs' has seen a significant evolution in its research themes, with certain topics gaining increased attention in recent publications. This section identifies emerging themes that are shaping the journal's current focus, reflecting contemporary issues and innovative research directions.
  1. Psychedelic-Assisted Therapies:
    There is a growing body of research investigating the applications of psychedelics in therapeutic settings, especially concerning mental health disorders such as depression, PTSD, and anxiety.
  2. Impact of Legalization and Policy Change:
    Emerging studies focus on the implications of drug legalization and policy changes, particularly surrounding cannabis and the societal impacts of these shifts.
  3. Intersection of Substance Use and Mental Health:
    Research increasingly explores the interplay between substance use and mental health, highlighting comorbidities and integrated treatment approaches.
  4. Community-Based Drug Interventions:
    There is an increasing emphasis on community-level interventions and harm reduction strategies that consider local cultural contexts and community health.
  5. Microdosing Practices and Effects:
    The phenomenon of psychedelic microdosing is gaining traction, with studies examining its effects on creativity, mental health, and overall well-being.

Declining or Waning

While the journal continues to publish a broad range of topics, certain themes appear to be declining in prominence over recent years. This section highlights the areas that have seen reduced focus or interest among researchers, indicating potential shifts in the field's priorities or emerging trends overshadowing these topics.
  1. Traditional Drug Use Studies:
    There is a noticeable decrease in studies focused solely on traditional or historical uses of substances without a contemporary context, reflecting a shift towards more applied and intervention-focused research.
  2. Basic Pharmacological Studies:
    Research centered on basic pharmacology of psychoactive substances, such as isolated pharmacodynamics or pharmacokinetics, has waned in favor of studies that address clinical implications and real-world applications.
  3. General Attitudes Towards Drug Use:
    Papers exploring general public attitudes towards drug use, without a specific focus on therapeutic or harm reduction implications, seem to be less frequently published.
  4. Non-Psychoactive Substances:
    Research on substances that are not considered psychoactive (e.g., certain dietary supplements or non-drug interventions) has become less common, as the journal's focus has shifted more towards psychoactive drugs.

Similar Journals

JOURNAL OF DRUG ISSUES

Advancing Knowledge in Drug Research
Publisher: SAGE PUBLICATIONS INCISSN: 0022-0426Frequency: 4 issues/year

JOURNAL OF DRUG ISSUES, published by SAGE PUBLICATIONS INC, serves as a pivotal platform for researchers and professionals dedicated to the multifaceted exploration of drug-related topics across various fields, including health, medicine, psychiatry, and public health. With an ISSN of 0022-0426 and an E-ISSN of 1945-1369, this esteemed journal has maintained a consistent output since its inception in 1971 and is set to continue its contributions through 2024. Reflecting its high academic standards, it has achieved a Q2 ranking in Health (Social Science) and Q3 rankings in several related categories, underscoring its relevance and influence among scholarly work. The journal is indexed in Scopus, with respectable rankings in various medical and health-related disciplines, highlighting its role as an essential resource for those invested in the vigorous discourse surrounding drug issues. Although not an open-access publication, the journal ensures that access to its extensive research findings remains available to a broad audience, solidifying its importance in advancing knowledge and informing best practices in the field.

DRUGS-EDUCATION PREVENTION AND POLICY

Shaping the future of drug policy with scholarly rigor.
Publisher: TAYLOR & FRANCIS LTDISSN: 0968-7637Frequency: 6 issues/year

DRUGS-EDUCATION PREVENTION AND POLICY is a premier scholarly journal published by Taylor & Francis Ltd, focusing on the critical intersection of drug education, prevention strategies, and policy formulation. Established in 1994 and continuing through its converged years into 2024, this journal holds significant relevance within the health and social sciences fields, with commendable standings reflected in its 2023 category quartile rankings of Q2 in both Health (Social Science) and Medicine (Miscellaneous). With an impact ranking that places it in the 73rd and 67th percentiles respectively, it serves as an influential platform for researchers, professionals, and students to disseminate innovative research, case studies, and policy analyses. Those interested in the complexities of drug-related issues are encouraged to explore the insights provided by this journal, contributing to the ongoing discourse in effective prevention and education practices in the context of drug use and its social implications. Although access to articles is not open, the wealth of knowledge presented is invaluable for academia and policy formulation alike.

DRUG AND ALCOHOL REVIEW

Bridging disciplines to tackle addiction challenges.
Publisher: WILEYISSN: 0959-5236Frequency: 6 issues/year

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Journal of Substance Use

Pioneering critical insights in health and social sciences.
Publisher: TAYLOR & FRANCIS INCISSN: 1465-9891Frequency: 6 issues/year

The Journal of Substance Use is a vital resource for researchers, professionals, and students in the fields of health and social sciences, published by Taylor & Francis Inc.. With an ISSN of 1465-9891 and E-ISSN of 1475-9942, this journal has been at the forefront of substance use research since its inception in 1996 and continues to provide a platform for the dissemination of innovative findings and critical analysis up to the year 2024. Ranking in the Q3 category for both Health (Social Science) and Medicine (Miscellaneous) in the 2023 quartiles, the journal encapsulates a broad spectrum of issues related to substance use, including addiction, intervention strategies, and policy implications. Although not an open-access journal, it remains accessible to a wide audience. With its substantial role in enhancing understanding and addressing the multi-faceted challenges of substance use, the Journal of Substance Use is essential for all stakeholders aiming to contribute to research and practice in this crucial area.

Alkoholizm i Narkomania-Alcoholism and Drug Addiction

Illuminating the path to recovery and understanding.
Publisher: INST PSYCHIATRY & NEUROLOGY, DEPT STUDIES ALCOHOLISMISSN: 0867-4361Frequency: 4 issues/year

Alkoholizm i Narkomania - Alcoholism and Drug Addiction is a prominent peer-reviewed journal published by the Institute of Psychiatry and Neurology, Department of Studies on Alcoholism in Warsaw, Poland. Renowned for its commitment to advancing the fields of addiction research and mental health, this journal disseminates critical findings regarding the prevention, treatment, and societal implications of alcoholism and drug addiction. Since becoming Open Access in 2017, it ensures that researchers, professionals, and students from across the globe have unrestricted access to valuable resources and emerging studies within this vital area of public health. The journal emphasizes innovative methodologies and interdisciplinary approaches, inviting contributions that explore the complex interplay of psychological, social, and biological factors influencing addiction. By fostering a collaborative and inclusive scholarly community, Alkoholizm i Narkomania aims to contribute significantly to the understanding and resolution of addiction-related challenges worldwide.

Substance Abuse-Research and Treatment

Fostering interdisciplinary dialogue for better mental health outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 1178-2218Frequency:

Substance Abuse: Research and Treatment is a premier open-access journal published by SAGE Publications Ltd, focusing on the multifaceted aspects of substance use and its impact on mental health. Since its establishment in 2008, this journal has been dedicated to disseminating innovative research findings, case studies, and reviews that enhance understanding and treatment of substance-related disorders. With an impact factor that reflects its standing in the field, currently ranked in the Q2 category of Psychiatry and Mental Health, Substance Abuse: Research and Treatment strives to foster interdisciplinary dialogue among researchers, practitioners, and students. By making its content freely accessible, the journal encourages widespread engagement and application of evidence-based practices to mitigate substance abuse issues. The journal’s diverse global perspectives make it a vital resource for anyone invested in advancing knowledge and improving treatment outcomes in this critical area of public health.

Nordic Studies on Alcohol and Drugs

Fostering Global Dialogue on Nordic Substance Use Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1455-0725Frequency: 6 issues/year

Nordic Studies on Alcohol and Drugs is a leading peer-reviewed journal published by SAGE PUBLICATIONS LTD, dedicated to advancing the understanding of alcohol and drug use from a Nordic perspective. Established in 1989 and operating as an Open Access journal since 2011, it provides a platform for researchers and professionals in the fields of health policy and social sciences, focusing on empirical research and interdisciplinary studies. With a commendable 2023 Impact Factor, ranking Q2 in both Health Policy and Health (Social Science), it has carved a significant niche in the scholarly community, fostering discussions around public health and drug-related issues. The journal covers diverse topics relevant to the Nordic context, making it a valuable resource for those seeking to understand patterns of alcohol and drug consumption and their implications. The journal reaches an international audience, underscoring its relevance across national borders, and aims to facilitate collaboration and knowledge sharing among scholars, practitioners, and policymakers.

AMERICAN JOURNAL ON ADDICTIONS

Advancing the Science of Addiction Treatment
Publisher: WILEYISSN: 1055-0496Frequency: 6 issues/year

The AMERICAN JOURNAL ON ADDICTIONS, published by WILEY, stands as a premier publication within the realms of Clinical Psychology, Medicine, and Psychiatry. With its ISSN 1055-0496 and E-ISSN 1521-0391, the journal has been a critical resource since its inception in 1992, consistently evolving to encompass a wide scope of addiction research and its implications on public health. Renowned for its rigorous peer-reviewed articles, it boasts impressive rankings, including Q1 status in both Clinical Psychology and Medicine (miscellaneous) for 2023, and a respectable Q2 in Psychiatry and Mental Health. As a foundational platform for disseminating cutting-edge research, the journal aims to facilitate the exchange of knowledge among researchers, healthcare professionals, and educators alike. Its significant impact on the academic community is underscored by its Scopus rankings—placing it in the top 26% of Clinical Psychology journals and the top 28% in Medicine (miscellaneous). By fostering an understanding of addiction and its treatments, the AMERICAN JOURNAL ON ADDICTIONS plays an essential role in guiding innovative practices and shaping future policies within the field.

Suchttherapie

Advancing the Dialogue on Addiction Treatment
Publisher: GEORG THIEME VERLAG KGISSN: 1439-9903Frequency: 4 issues/year

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

Substance Abuse Treatment Prevention and Policy

Innovative insights for effective prevention and policy.
Publisher: BMCISSN: Frequency: 1 issue/year

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.